409 related articles for article (PubMed ID: 11881427)
21. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
22. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload.
Johnson DW; Arndt M; O'Shea A; Watt R; Hamilton J; Vincent K
BMC Nephrol; 2001 Dec; 2():2. PubMed ID: 11737871
[TBL] [Abstract][Full Text] [Related]
23. Polyglucose dialysis solution induces changes in blood chemistry.
Grzegorzewska AE; Antczak-Jedrzejczak D; Leander M; Mariak I
Adv Perit Dial; 2001; 17():101-8. PubMed ID: 11510254
[TBL] [Abstract][Full Text] [Related]
24. Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; van Dorp W; Peers EM; Verbrugh HA
Perit Dial Int; 1997; 17(6):602-7. PubMed ID: 9655161
[TBL] [Abstract][Full Text] [Related]
25. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
Ota K; Akiba T; Nakao T; Nakayama M; Maeba T; Park MS; Tranaeus A; Yorioka N;
Perit Dial Int; 2003; 23(4):356-61. PubMed ID: 12968843
[TBL] [Abstract][Full Text] [Related]
26. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
[TBL] [Abstract][Full Text] [Related]
27. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease.
Kanbay M; Bavbek N; Delibasi T; Koca C; Kaya A; Altay M; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2007; 29(3):309-13. PubMed ID: 17497445
[TBL] [Abstract][Full Text] [Related]
28. Review of clinical trial experience with icodextrin.
Wolfson M; Ogrinc F; Mujais S
Kidney Int Suppl; 2002 Oct; (81):S46-52. PubMed ID: 12230481
[No Abstract] [Full Text] [Related]
29. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients.
Amici G; Orrasch M; Da Rin G; Bocci C
Adv Perit Dial; 2001; 17():80-3. PubMed ID: 11510303
[TBL] [Abstract][Full Text] [Related]
30. Severe peritoneal mononucleosis associated with icodextrin use in continuous ambulatory peritoneal dialysis.
Martín J; Sansone G; Cirugeda A; Sánchez-Tomero JA; Muñoz C; Selgas R
Adv Perit Dial; 2003; 19():191-4. PubMed ID: 14763060
[TBL] [Abstract][Full Text] [Related]
31. Allergic reactions to the polymeric glucose-based peritoneal dialysis fluid icodextrin in patients with renal failure.
Goldsmith D; Jayawardene S; Sabharwal N; Cooney K
Lancet; 2000 Mar; 355(9207):897. PubMed ID: 10752708
[TBL] [Abstract][Full Text] [Related]
32. The utility of two daytime icodextrin exchanges to reduce dextrose exposure in automated peritoneal dialysis patients: a pilot study of nine patients.
Gobin J; Fernando S; Santacroce S; Finkelstein FO
Blood Purif; 2008; 26(3):279-83. PubMed ID: 18421212
[TBL] [Abstract][Full Text] [Related]
33. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
[TBL] [Abstract][Full Text] [Related]
35. [Peritoneal equilibrium test using icodextrin and glucose at different concentrations].
Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Gallego T; Delgado-Pecellín C; Benítez M; Torán CD
Nefrologia; 2002; 22(4):340-7. PubMed ID: 12369125
[TBL] [Abstract][Full Text] [Related]
36. Severe cutaneous hypersensitivity requiring permanent icodextrin withdrawal in a CAPD patient.
Queffeulou G; Bernard M; Vrtovsnik F; Skhiri H; Lebrun-Vigne B; Hufnagel G; Michel C; Mignon F
Clin Nephrol; 1999 Mar; 51(3):184-6. PubMed ID: 10099892
[TBL] [Abstract][Full Text] [Related]
37. [Icodextrin in peritoneal dialysis therapy].
Grzegorzewska AE; Antczak-Jedrzejczak D
Przegl Lek; 1999; 56(12):812-6. PubMed ID: 10789195
[TBL] [Abstract][Full Text] [Related]
38. Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis.
Chow KM; Szeto CC; Kwan BC; Pang WF; Ma T; Leung CB; Law MC; Li PK
Nephrol Dial Transplant; 2014 Jul; 29(7):1438-43. PubMed ID: 24578470
[TBL] [Abstract][Full Text] [Related]
39. Icodextrin: an alternative peritoneal dialysis fluid.
Chhabra D; Nash K
Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1455-64. PubMed ID: 18950286
[TBL] [Abstract][Full Text] [Related]
40. Successful use of icodextrin in elderly patients on continuous ambulatory peritoneal dialysis.
Nakamoto H; Babazono T; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Yorioka N; Sato M; Yamabe K; Kawaguchi Y
Adv Perit Dial; 2005; 21():168-74. PubMed ID: 16686312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
